{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T17:34:39Z","timestamp":1793208879369,"version":"4.5.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Totally implantable venous access devices are essential for long-term care in pediatric cancer patients, but they can cause catheter-associated bloodstream infections (CLABSIs). While central line bundles have proven effective in preventing CLABSIs in inpatient settings, data on adjunct prevention strategies, such as 70% isopropyl alcohol-impregnated disinfecting caps, in ambulatory pediatric oncology patients are limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>To assess the impact of 70% isopropyl alcohol\u2013impregnated disinfecting caps on the rate and cost of CLABSIs in ambulatory pediatric hematology-oncology patients with ports.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This study compared 2 distinct periods at an outpatient clinic: control group (n=58) and a study group using 70% isopropyl alcohol\u2013impregnated disinfecting caps (n=34). The primary outcome was the CLABSI rate per 1000 catheter-days. Secondary outcomes included attributable health care costs and cost-effectiveness analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The CLABSI rate was 13.55\/1000 catheter-days in the control group and 2.05\/1000 catheter-days in the study group, reflecting an 84.9% reduction. The cost analysis demonstrated that the intervention was cost-effective, with estimated savings ranging from $2637.68 to $10,916.67 and a return on investment of up to 9.641%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Implementation of 70% isopropyl alcohol\u2013impregnated disinfecting caps resulted in a substantial clinical reduction in ambulatory CLABSI incidence and yielded significant cost savings in this high-risk population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mph.0000000000003272","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T17:00:32Z","timestamp":1789491632000},"page":"e457-e461","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Clinical and Economic Impact of 70% Isopropyl Alcohol\u2013Impregnated Disinfecting Caps on CLABSI Rates in Ambulatory Pediatric Hematology-Oncology Patients"],"prefix":"10.1097","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6053-8027","authenticated-orcid":false,"given":"\u0130lker","family":"Devrim","sequence":"first","affiliation":[{"name":"Department of Pediatric Infectious Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deniz","family":"Ergun","sequence":"additional","affiliation":[{"name":"Department of Pediatric Infectious Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0721-3511","authenticated-orcid":false,"given":"Hincal","family":"Ozbakir","sequence":"additional","affiliation":[{"name":"Department of Pediatric Infectious Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u0131nar","family":"\u00c7i\u00e7ek","sequence":"additional","affiliation":[{"name":"Hematology Oncology Outpatient Unit"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selma","family":"Uslu","sequence":"additional","affiliation":[{"name":"Hematology Oncology Outpatient Unit"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Canan","family":"Dinc","sequence":"additional","affiliation":[{"name":"Nurse, Infections Control Committee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6504-2748","authenticated-orcid":false,"given":"Yeliz","family":"Oruc","sequence":"additional","affiliation":[{"name":"Nurse, Infections Control Committee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6772-237X","authenticated-orcid":false,"given":"\u015eerife \u015e.\u00d6.","family":"G\u00f6ktepe","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology and Oncology, Dr. Beh\u00e7et Uz Children\u2019s Diseases and Surgery Training and Research Hospital, \u0130zmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beg\u00fcmhan D.","family":"G\u00fcndo\u011fan","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology and Oncology, Dr. Beh\u00e7et Uz Children\u2019s Diseases and Surgery Training and Research Hospital, \u0130zmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamiyet H.","family":"\u00d6zdemir","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology and Oncology, Dr. Beh\u00e7et Uz Children\u2019s Diseases and Surgery Training and Research Hospital, \u0130zmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bengu","family":"Demirag","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology and Oncology, Dr. Beh\u00e7et Uz Children\u2019s Diseases and Surgery Training and Research Hospital, \u0130zmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye\u015fim","family":"Oymak","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology and Oncology, Dr. Beh\u00e7et Uz Children\u2019s Diseases and Surgery Training and Research Hospital, \u0130zmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuba H.","family":"Karap\u0131nar","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology and Oncology, Dr. Beh\u00e7et Uz Children\u2019s Diseases and Surgery Training and Research Hospital, \u0130zmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,9,14]]},"reference":[{"key":"R1-20261028","first-page":"25","article-title":"Long-term catheterization: current approaches in the diagnosis and treatment of port-related infections","volume":"7","author":"Bustos","year":"2014","journal-title":"Infect Drug Resist"},{"key":"R2-20261028","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1186\/s12957-015-0707-2","article-title":"Port type is a possible risk factor for implantable venous access port-related bloodstream infections and no sign of local infection predicts the growth of gram-negative bacilli","volume":"13","author":"Hsu","year":"2015","journal-title":"World J Surg Oncol"},{"key":"R3-20261028","doi-asserted-by":"crossref","first-page":"e996","DOI":"10.1542\/peds.2012-0295","article-title":"Implementation of a central line maintenance care bundle in hospitalized pediatric oncology patients","volume":"130","author":"Rinke","year":"2012","journal-title":"Pediatrics"},{"key":"R4-20261028","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/pbc.24187","article-title":"Rapid reduction of central line infections in hospitalized pediatric oncology patients through simple quality improvement methods","volume":"60","author":"Choi","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"R5-20261028","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.ajic.2011.06.002","article-title":"Preventive strategies for central line-associated bloodstream infections in pediatric hematopoietic stem cell transplant recipients","volume":"40","author":"Barrell","year":"2012","journal-title":"Am J Infect Control"},{"key":"R6-20261028","first-page":"Doc15","article-title":"Impact of a modified Broviac maintenance care bundle on bloodstream infections in paediatric cancer patients","volume":"10","author":"Furtw\u00e4ngler","year":"2015","journal-title":"GMS Hyg Infect Control"},{"key":"R7-20261028","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/17571774231191334","article-title":"The evaluation of Candida-related central line-related bloodstream infections in pediatric cancer patients: a pre- and post-intervention study","volume":"24","author":"Devrim","year":"2023","journal-title":"J Infect Prev"},{"key":"R8-20261028","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1186\/s12913-020-05221-6","article-title":"Central line bundle including split-septum device and single-use prefilled flushing syringes to prevent port-associated bloodstream infections: a cost and resource-utilization analysis","volume":"20","author":"Devrim","year":"2020","journal-title":"BMC Health Serv Res"},{"key":"R9-20261028","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1177\/1129729818757955","article-title":"Central line bundle for prevention of central line-associated bloodstream infection for totally implantable venous access devices (ports) in pediatric cancer patients","volume":"19","author":"Devrim","year":"2018","journal-title":"J Vasc Access"},{"key":"R10-20261028","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ijid.2019.04.014","article-title":"Managing and preventing vascular catheter infections: a position paper of the International Society for Infectious Diseases","volume":"84","author":"Lutwick","year":"2019","journal-title":"Int J Infect Dis"},{"issue":"suppl 1","key":"R11-20261028","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/NAN.0000000000000532","article-title":"Infusion Therapy Standards of Practice, 9th edition","volume":"47","author":"Nickel","year":"2024","journal-title":"J Infus Nurs"},{"key":"R12-20261028","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/cid\/cir138","article-title":"Summary of recommendations: guidelines for the prevention of intravascular catheter-related infections","volume":"52","author":"O\u2019Grady","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R13-20261028","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.12968\/bjon.2016.25.8.S25","article-title":"Port protectors in clinical practice: an audit","volume":"25","author":"Cameron-Watson","year":"2016","journal-title":"Br J Nurs"},{"key":"R14-20261028","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.burns.2017.01.010","article-title":"Efforts of a Unit Practice Council to implement practice change utilizing alcohol impregnated port protectors in a burn ICU","volume":"43","author":"Martino","year":"2017","journal-title":"Burns"},{"key":"R15-20261028","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.ajic.2014.09.008","article-title":"Impact of universal disinfectant cap implementation on central line-associated bloodstream infections","volume":"42","author":"Merrill","year":"2014","journal-title":"Am J Infect Control"},{"key":"R16-20261028","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.ajic.2012.01.025","article-title":"Impact of alcohol-impregnated port protectors and needleless neutral pressure connectors on central line-associated bloodstream infections and contamination of blood cultures in an inpatient oncology unit","volume":"40","author":"Sweet","year":"2012","journal-title":"Am J Infect Control"},{"key":"R17-20261028","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.java.2012.10.002","article-title":"Central venous catheter protective connector caps reduce intraluminal catheter-related infection","volume":"17","author":"Ramirez","year":"2012","journal-title":"J Assoc Vasc Access"},{"key":"R18-20261028","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1017\/ice.2020.467","article-title":"Alcohol-impregnated caps and ambulatory central-line-associated bloodstream infections (CLABSIs): a randomized clinical trial","volume":"42","author":"Milstone","year":"2021","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R19-20261028","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/NAN.0000000000000612","article-title":"The impact of 70% isopropyl alcohol-impregnated disinfecting caps on needleless connector colonization in ambulatory pediatric hematology-oncology patients","volume":"48","author":"Devrim","year":"2025","journal-title":"J Infus Nurs"},{"key":"R20-20261028","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.ajic.2017.12.012","article-title":"Healthcare-associated infections studies project: an American Journal of Infection Control and National Healthcare Safety Network data quality collaboration: location mapping","volume":"46","author":"Wright","year":"2018","journal-title":"Am J Infect Control"},{"key":"R21-20261028","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1002\/pbc.24677","article-title":"Ambulatory pediatric oncology CLABSIs: epidemiology and risk factors","volume":"60","author":"Rinke","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"R23-20261028","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/pbc.21497","article-title":"Risk determinants for catheter-associated blood stream infections in children and young adults with cancer","volume":"51","author":"Allen","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"R24-20261028","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1086\/525265","article-title":"Polymicrobial bloodstream infections among children and adolescents with central venous catheters evaluated in ambulatory care","volume":"46","author":"Downes","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R25-20261028","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.ijheh.2009.01.003","article-title":"Bloodstream infections in a German paediatric oncology unit: prolongation of inpatient treatment and additional costs","volume":"212","author":"Biwersi","year":"2009","journal-title":"Int J Hyg Environ Health"},{"key":"R26-20261028","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.ajic.2014.07.025","article-title":"Attributable costs of central line-associated bloodstream infections in a pediatric hematology\/oncology population","volume":"42","author":"Wilson","year":"2014","journal-title":"Am J Infect Control"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MPH.0000000000003272","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T17:00:47Z","timestamp":1793206847000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MPH.0000000000003272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,14]]},"references-count":25,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000003272","relation":{},"ISSN":["1077-4114","1536-3678"],"issn-type":[{"value":"1077-4114","type":"print"},{"value":"1536-3678","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,14]]},"assertion":[{"value":"2026-04-14","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-21","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}